Utama › Kanser Prostat › Oregon › Portland
Kajian klinikal Kanser Prostat di Portland, OR
33 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Portland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Mengambil pesertaFasa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mi jauh
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Mengambil pesertaFasa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Mengambil pesertaFasa 4
- Oregon Health & Science University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Mengambil pesertaFasa 1
- Oregon Health And Science University, Portland
Precision-Based Genomics in Prostate Cancer
Mengambil pesertaKajian pemerhatian
- Oregon Health Sciences University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Mengambil pesertaFasa 1
- Providence Portland Medical Center, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Mengambil pesertaFasa 2
- VA Portland Health Care System, Portland, OR, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Mengambil pesertaFasa 2
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Mengambil peserta
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Mengambil pesertaFasa 2
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Mengambil pesertaFasa 3
- Research Site, Portland
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Mengambil pesertaFasa 2
- VA Portland Health Care System, Portland, OR, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Mengambil pesertaFasa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- dan 1 lagi
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- dan 1 lagi
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Mengambil pesertaFasa 1/2
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Mengambil pesertaFasa 2
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Mengambil pesertaKajian pemerhatian
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Mengambil peserta
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Mengambil peserta
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Mengambil pesertaFasa 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- dan 1 lagi
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Mengambil pesertaFasa 2
- VA Portland Healthcare System, Portland
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Portland
- Kanser Paru-paru Bukan Sel Kecil46 kajian
- Kanser (semua jenis)34 kajian
- Kanser Payudara33 kajian
- Kanser Metastatik29 kajian
- Kanser Kolorektal28 kajian
- Kanser Ovari27 kajian
- Kanser Paru-paru26 kajian
- Leukemia Mieloid Akut25 kajian
- Kanser Endometrium24 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher19 kajian
- Kanser Pankreas19 kajian
- Kegagalan Jantung17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.